Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 135-142

  Yang, Chun ^a   Wen, Yugang ^b   Li, Hai ^a   Zhang, Dong ^a   Zhang, Ningmei ^a   Shi, Xinrong ^a   Jiang, Bo ^a   Ma, Xiaoqiang ^a   Yang, Ping ^a   Tang, Huamei ^b   Peng, Zhihai ^b   Yang, Yinxue ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gastric cancer; Immunohistochemistry; Minichromosome maintenance 2; Prognosis; Survival analysis

Indexed keywords

COMPLEMENTARY DNA; CYCLINE; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 2;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL CYCLE PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855266304     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1473     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Malekzadeh R, Derakhshan MH and Malekzadeh Z: Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 12: 576-583, 2009.
3. El-Rifai W and Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol 12: 128-140, 2002. (Pubitemid 34522349)
4. Nishitani H and Lygerou Z: Control of DNA replication licensing in a cell cycle. Genes Cells 7: 523-534, 2002. (Pubitemid 34679050)
5. Tye BK: MCM proteins in DNA replication. Annu Rev Biochem 68: 649-686, 1999.
6. Labib K, Tercero JA and Diffley JF: Uninterrupted MCM2-7 function required for DNA replication fork progression. Science 288: 1643-1647, 2000. (Pubitemid 30387430)
7. Pacek M, Tutter AV, Kubota Y, Takisawa H and Walter JC: Localization of MCM2-7, Cdc45, and GINS to the site of DNA unwinding during eukaryotic DNA replication. Mol Cell 21: 581-587, 2006. (Pubitemid 43228013)
8. Romanowski P and Madine MA: Mechanisms restricting DNA replication to once per cell cycle: the role of Cdc6p and ORC. Trends Cell Biol 7: 9-10, 1997. (Pubitemid 27056377)
9. Tan DF, Huberman JA, Hyland A, et al.: MCM2 - a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer 1: 6, 2001.
10. Kearsey SE and Labib K: MCM proteins: evolution, properties, and role in DNA replication. Biochim Biophys Acta 1398: 113-136, 1998. (Pubitemid 28305206)
11. Todorov IT, Werness BA, Wang HQ, et al.: HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest 78: 73-78, 1998. (Pubitemid 28074310)
12. Maiorano D, Lutzmann M and Mechali M: MCM proteins and DNA replication. Curr Opin Cell Biol 18: 130-136, 2006. (Pubitemid 43375879)
13. Mincheva A, Todorov I, Werner D, Fink TM and Lichter P: The human gene for nuclear protein BM28 (CDCL1), a new member of the early S-phase family of proteins, maps to chromosome band 3q21. Cytogenet Cell Genet 65: 276-277, 1994. (Pubitemid 24028417)
14. Rodins K, Cheale M, Coleman N and Fox SB: Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res 8: 1075-1081, 2002. (Pubitemid 35177358)
15. Hunt DP, Freeman A, Morris LS, et al.: Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein. Br J Neurosurg 16: 10-15, 2002. (Pubitemid 34246180)
16. Kato H, Miyazaki T, Fukai Y, et al.: A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. J Surg Oncol 84: 24-30, 2003. (Pubitemid 37075691)
17. Gonzalez MA, Pinder SE, Callagy G, et al.: Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 21: 4306-4313, 2003. (Pubitemid 46628462)
18. Hashimoto K, Araki K, Osaki M, Nakamura H, Tomita K, Shimizu E and Ito H: MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications. Pathobiology 71: 193-200, 2004. (Pubitemid 38969877)
19. Skotnicka-Klonowicz G, Kobos J, Los E, Trejster E, Szymik-Kantorowicz S and Daszkiewicz P: Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children. Eur J Surg Oncol 28: 67-71, 2002. (Pubitemid 41122786)
20. Dutta A and Bell SP: Initiation of DNA replication in eukaryotic cells. Annu Rev Cell Dev Biol 13: 293-332, 1997. (Pubitemid 28034528)
21. Wang Y, Li Y, Zhang WY, et al.: mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma. Eur J Cancer Prev 18: 40-45, 2009.
22. Kodani I, Shomori K, Osaki M, Kuratate I, Ryoke K and Ito H: Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology 69: 150-158, 2001. (Pubitemid 34212086)
23. Wharton SB, Chan KK, Anderson JR, Stoeber K and Williams GH: Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol 27: 305-313, 2001. (Pubitemid 32768551)
24. Meng MV, Grossfeld GD, Williams GH, et al.: Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 7: 2712-2718, 2001. (Pubitemid 32911375)
25. Dudderidge TJ, Stoeber K, Loddo M, Atkinson G, Fanshawe T, Griffiths DF and Williams GH: Mcm2, Geminin, and Ki67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 11: 2510-2517, 2005. (Pubitemid 40569447)
26. Padmanabhan V, Callas P, Philips G, Trainer TD and Beatty BG: DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 57: 1057-1062, 2004. (Pubitemid 39331356)
27. Czyzewska J, Guzinska-Ustymowicz K, Pryczynicz A, Kemona A and Bandurski R: Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer. Folia Histochem Cytobiol 47: 289-296, 2009.
28. Mita T and Shimoda T: Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity. J Gastroenterol 36: 661-668, 2001. (Pubitemid 33040938)